Big Gain For Sutro Biopharma, Inc.
Sutro Biopharma, Inc. (STRO:NASDAQ) shot up at $22.65, a gain of 33.2%. The stock got featured on our News Catalysts scanner on Fri 04 Dec 20 at 02:53 PM in the 'BIOTECH' category. From Thu 19 Nov 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Sutro Biopharma, Inc. (STRO:NASDAQ)
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Top 10 Gainers:
- STPK (STPK:NYSE), 69.09%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 47.23%
- China HGS Real Estate Inc. (HGSH:NASDAQ), 46.59%
- Top Ships Inc. (TOPS:NASDAQ), 38.66%
- LAZR (LAZR:NASDAQ), 36.64%
- Sutro Biopharma, Inc. (STRO:NASDAQ), 33.24%
- Sotherly Hotels Inc. (SOHO:NASDAQ), 32.35%
- Seanergy Maritime Holdings Corp. (SHIP:NASDAQ), 31.13%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 28.85%
- Funko, Inc. (FNKO:NASDAQ), 28.84%